About Our Speaker – Dawn Kusler, Pharm D

Dawn Ipsen

Dawn Ipsen

Pharm D

Dawn Ipsen, PharmD is owner and pharmacist of Clark’s Compounding Pharmacy in Bellevue, WA and Kusler’s Compounding Pharmacy in Snohomish, WA. Dawn graduated from the University of Washington with a Doctorate of Pharmacy in 2001 where she received the Dean’s Outstanding Service Award. She holds memberships with the Alliance for Pharmacy Compounding and Washington State Pharmacy Association. She is a Clinical Instructor for the University of Washington School of Pharmacy and an Affiliate Faculty Member for Bastyr University. She is a Pharmacist Preceptor for Washington State and teaches Doctorate of Pharmacy students. Dawn also serves on the Professional Compounding Centers of America (PCCA) Advisory Counsel and Chair of the WSPA Compounding Special Interest Group. She was named UW School of Pharmacy 2020 Distinguished Alumni Award for Excellence in Pharmacy Practice. Dawn has presented on the topic of pharmaceutical compounding to healthcare provider, patient, and peer groups. She is dedicated to helping her community find solutions to medication problems through personalized medication therapies.

Dawn Ipsen’s Upcoming Sessions

Compounded formulations and prescriptions for dermatologic and pain conditions in women: acne vulgaris, acne rosacea, hair loss, wounds, burns, scars, psoriasis, atopic dermatitis, neuropathic pain, topical for OA

As women age, many have a strong desire to not only continue to feel good, but to also look great. Some of the most common dermatology concerns that women seek medical treatment from primary care providers and women’s health experts include acne, rosacea, hyperpigmentation, wrinkles, scarring, alopecia, psoriasis, and others. Clinic pearls and tools from both traditional medications and compounding pharmacy opportunities that you can quickly implement into your practice leading to enthusiastically satisfied patient results.


We are now FULLY Accredited with the NANCEAC. We have submitted the October CEU and expect to have the full 13 approved.


join our mailing list
* indicates required

Dr. Hudson’s Blog

Enter your email address below to subscribe to our Research Feed:

Related Events